Mestinon 10

Pyridostigmine bromide, the active ingredient in Mestinon 10, is a cholinesterase inhibitor presented as an oral tablet for oral administration. It works by increasing acetylcholine at neuromuscular junctions and is used to improve muscle strength in patients with myasthenia gravis and to alleviate symptoms of orthostatic hypotension.

GNH USA supplies Mestinon 10 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides reliable global distribution.

Mestinon (pyridostigmine bromide) is used in disorders that involve impaired neuromuscular transmission.

- Myasthenia gravis: improves skeletal muscle strength and reduces fatigue. - Orthostatic hypotension: lessens the drop in blood pressure upon standing. - Myasthenic crisis: supports respiratory muscle function during acute exacerbations.

Common side effects are usually mild and related to increased cholinergic activity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools occurring after dosing. - Abdominal cramps: intermittent stomach discomfort. - Increased salivation: excess drooling or oral secretions. - Muscle cramps: involuntary tightening of skeletal muscles. - Sweating: excessive perspiration.

Serious or Rare Side Effects: - Cholinergic crisis: severe muscle weakness and respiratory failure. - Bradycardia: markedly slow heart rate requiring monitoring. - Bronchospasm: narrowing of airways causing breathing difficulty. - Seizures: rare convulsive episodes. - Anaphylaxis: life‑threatening allergic reaction. - Severe rash or skin eruption: indicative of hypersensitivity.

Before initiating therapy, consider the following safety measures.

- Dose titration: adjust gradually based on clinical response and tolerance. - Renal impairment: monitor renal function and modify dose if needed. - Cardiac disease: use cautiously in patients with bradyarrhythmias. - Pregnancy: risk category unknown; discuss potential benefits and risks with a healthcare professional. - Concomitant anticholinergic drugs: may reduce therapeutic effect. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Pyridostigmine bromide can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Beta‑blockers: may exacerbate bradycardia. - Muscarinic antagonists (e.g., atropine): antagonize pyridostigmine’s action. - Other cholinesterase inhibitors: additive cholinergic effects can lead to toxicity.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance hypotensive response. - Anesthetic agents (e.g., succinylcholine): prolonged neuromuscular blockade. - Diuretics: potential electrolyte disturbances requiring monitoring.